TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

Full description

Bibliographic Details
Main Authors: E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2011-06-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis, interleukin-6
interleukin-6 receptors
tocilizumab, erythrocyte sedimentation rate
c-reactive protein, igm/iga rheumatoid factor
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
Online Access:https://rsp.mediar-press.net/rsp/article/view/705

Internet

https://rsp.mediar-press.net/rsp/article/view/705

Similar Items